Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids. (2021)
Attributed to:
Engineering Multi-functional Nanomaterials to Treat Metastatic Cancer
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2021.121018
PubMed Identifier: 34416329
Publication URI: http://europepmc.org/abstract/MED/34416329
Type: Journal Article/Review
Volume: 607
Parent Publication: International journal of pharmaceutics
ISSN: 0378-5173